Germany · Venture startup

Who invested in CellZome

2 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$63Mraised across 2 rounds since 2001, from 2 sources

$31MSeries B$32MVenture
Latest round
Venture, $32MMar 2003
Investors
10
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20022003
$31MSeries B$32MVenture
First round
Series B, $31M
Mar 2001
Biggest round
$32M
Venture · Mar 2003
Between rounds
2.1 years
from the last two

The rounds

  1. Mar 2003
  2. Mar 2001

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Atlas VentureVC firm2rounds
Advent InternationalPrivate equity2rounds
Index VenturesVC firm1round
Schroder VenturesPrivate equity1round
Schroders PlcGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about CellZome

Who invested in CellZome?

CellZome's investors include Atlas Venture, Advent International, Index Ventures, Sofinnova Investments and Invesco Private Capital, and 5 more on record.

How much has CellZome raised?

CellZome has raised $63M across 2 rounds since 2001.

When did CellZome last raise?

CellZome's most recent round was a Venture of $32M in Mar 2003.

What was CellZome's biggest round?

Its most recent round, $32M in Mar 2003, is also its largest on record.

Who backed CellZome first?

CellZome's first round on record, in Mar 2001, was backed by Index Ventures, Atlas Venture and Sofinnova Investments and 3 others.

What stage is CellZome at?

CellZome's latest named round is a Venture, in Mar 2003.

Where is CellZome based?

CellZome is based in Germany.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.